Free Trial

Aerovate Therapeutics (AVTE) SEC Filings & 10K Form

$1.89
-0.01 (-0.53%)
(As of 12:48 PM ET)

Recent Aerovate Therapeutics SEC Filings

DateFilerForm TypeView
08/12/2024
3:31 PM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
7:00 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:00 PM
Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
06/20/2024
4:56 PM
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:35 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:44 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
4:00 PM
Aerovate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
7:29 PM
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:10 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:10 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:57 PM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:39 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
4:59 PM
Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
3:16 PM
Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
04/26/2024
4:23 PM
Aerovate Therapeutics (Filer)
Form ARS
04/26/2024
6:18 AM
Aerovate Therapeutics (Filer)
Form DEF 14A
04/26/2024
6:19 AM
Aerovate Therapeutics (Filer)
Form DEFA14A
04/19/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:35 PM
Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:35 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:25 PM
Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
5:00 PM
Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:42 PM
Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

04/01/2024
6:18 PM
Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
6:24 PM
Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:31 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
8:22 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:15 PM
Aerovate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
3:12 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:35 PM
Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:37 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
2:28 PM
Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:34 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
6:09 PM
Aerovate Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
Form SC 13D/A
02/20/2024
5:38 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
3:28 PM
Aerovate Therapeutics (Subject)
TCG Crossover GP I, LLC (Filed by)
Form SC 13G
02/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:45 PM
Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Pigot Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:29 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:11 PM
Aerovate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/08/2024
6:59 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:17 PM
Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
5:00 PM
Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
4:50 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:24 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2023
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:10 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/07/2023
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
5:00 PM
Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

12/05/2023
7:04 PM
Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
5:00 PM
Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:13 PM
Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
3:17 PM
Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
3:46 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:16 AM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
7:03 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AVTE) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners